Obagi Medical Products confirmed that Voce Capital has submitted to the company a notice of intent to nominate a slate of candidates to replace the Obagi Board of Directors at the company’s 2013 Annual Meeting of Stockholders. Obagi issued the following statement: The Obagi Board of Directors and management team are committed to acting in the best interests of the company and its stockholders, including considering options that fully reflect the value and prospects of the company. The Board is actively engaged in overseeing management's execution of the company’s strategic plan, which includes further penetrating its existing physician channel, launching its e-commerce platform and expanding in international markets. The Board is confident that this strategy will result in significant value for all stockholders.
- Board & Management Changes